The optimal treatment approach must be based on important prognostic and predictive factors, such as tumor size, number of lymph nodes involved, tumor grade and histological type, HER2 and hormonal status (ER/PgR), Ki-67, comorbidities, lymphovascular and perineural invasion, as well as age and general status of the patient. Here, ESR1 is linked to neoplasm.